Researchers at Dana-Farber Cancer Institute have been awarded $25 million for a project that seeks to determine how certain microbes inside the body can lead to colorectal cancer and influence a patient’s response to treatment. The team of doctors beat out more than 130 teams from all over the world to win the Grand Challenge, a competition funded by a cancer treatment and awareness charity in the United Kingdom. Known as the OPTIMISTICC project, the investigators will seek to understand the difference between a healthy microbiome and a microbiome associated with cancer.
Matthew Meyerson, MD, PhD
Wendy Garrett, MD, PhD